Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE
08/17 RECENT FINDINGS FROM GLAXOSMITHKLINE : 01 biomarker for...
08/17 Drugmaker Hikma trims sales forecasts, shares fall
08/15 GLAXOSMITHKLINE PLC. (ADR)(NYSE : GSK) Restructuring Takes A Toll on Ionis Pharm..
08/14 Featured Company News – GlaxoSmithKline Drops Options to Licence Inoter..
08/11 GLAXOSMITHKLINE PLC (ADR) (NYSE : GSK) And Rolls Royce To Expect UK Fraud Office..
08/10 Income investors run for cover as dependable UK dividends in jeopardy
08/10 Worst day in four months for FTSE as ex-divs, housebuilders weigh
08/10 GLAXOSMITHKLINE : Studies from GlaxoSmithKline plc Provide New Data on Pharmacog..
08/10DJMylan Cuts View On Drug Delays -- WSJ
08/10 GLAXOSMITHKLINE : ex-dividend day for interim dividend
More news
News from SeekingAlpha
08/17 'Safer' Dividend Follower Favorites And Rogues Led By RAIT Financial & Chico,..
08/16 Biogen's Alzheimer's Hope Tops The Sector's Most Valuable Pipeline Projects
08/15 BRISTOL-MYERS SQUIBB : HIV Franchise Was Never A Big Part Of The Game Plan
08/14 Gilead's Newer Tenofovir Patents Might Aid Its HIV Franchise
08/14 Ionis Absorbs Glaxo Rare Disease Cull
Financials ( GBP)
Sales 2017 30 168 M
EBIT 2017 8 507 M
Net income 2017 4 165 M
Debt 2017 14 104 M
Yield 2017 5,32%
P/E ratio 2017 19,62
P/E ratio 2018 15,93
EV / Sales 2017 2,92x
EV / Sales 2018 2,82x
Capitalization 73 974 M
Chart GLAXOSMITHKLINE
Duration : Period :
GlaxoSmithKline Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 17,4  GBP
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Emma Walmsley Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Patrick J. T. Vallance Executive Director, President-R&D
Roy Malcolm Anderson Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE-3.71%95 424
JOHNSON & JOHNSON15.77%360 112
NOVARTIS10.12%220 515
ROCHE HOLDING LTD.5.33%218 264
PFIZER2.71%198 663
MERCK AND COMPANY6.51%171 005